News

Find out how 30 partners have established world-class facilities, under the European Innovative Medicines Initiative.

€196 million pan-European drug discovery platform launched Large pharmaceutical companies join forces with small and medium-sized enterprises (SMEs) and academia in an IMI-supported public private partnership (PPP) to enhance early drug discovery and so address the ever-increasing need for innovative therapeutics to tackle unmet medical needs.